Avicanna

Advantage

Disrupting the Cannabinoid
Industry with Science

A Leader in Biopharmaceutical Advancements with Natural Cannabinoids

Avicanna is a Canadian vertically-integrated biopharmaceutical company focused on evidence-based utility of cannabinoids.

Commercial stage with diversified and high margin income streams in Canada, USA, and Latin America

  1. Comprehensive commercial portfolio – consumer retail, and medical cannabis
  1. Multinational with international foot-print – USA, Canada, and LATAM
  1. Partnership with Medical Cannabis by Shopper’s Drug Mart Inc. – RHO Phyto and Pura Earth branded nation-wide in Canada

Proven scientific platform, including R&D, pre-clinical and clinical infrastructure

  1. Cannabinoid drug development expertise – 20+ advanced commercial products and pharmaceutical pipeline
  1. World-Class collaborations – with leading Canadian academic and clinical institutions
  1. JLABS @ Toronto, Johnson & Johnson Innovation Centre in the MaRS Discovery District, R&D headquarters

Established and Proven low-cost vertical integration

  1. Two (2) Colombian majority-owned subsidiaries – cultivation footprint of 480,000 sq feet with industrial extraction capacity
  1. Organic and sustainable cultivation – ranked highest amongst global cannabis companies in a corporate sustainability assessment – issued by S&P Global in 2020

Hemp-derived Consumer Retail Products

Medical Products

Pharmaceutical Pipeline

Active Pharmaceutical Ingredients

Genetics and Seeds